A detailed history of Advisor Group Holdings, Inc. transactions in Cortexyme, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 277 shares of CRTX stock, worth $357. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277
Previous 277 -0.0%
Holding current value
$357
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$2.22 - $6.7 $614 - $1,855
277 New
277 $1,000
Q1 2022

May 04, 2022

SELL
$4.18 - $13.39 $2,399 - $7,685
-574 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$52.0 - $120.21 $26,312 - $60,826
-506 Reduced 46.85%
574 $53,000
Q2 2021

Aug 02, 2021

BUY
$31.88 - $58.66 $18,490 - $34,022
580 Added 116.0%
1,080 $58,000
Q1 2021

May 13, 2021

BUY
$28.6 - $49.21 $14,300 - $24,605
500 New
500 $18,000
Q2 2020

Aug 14, 2020

SELL
$34.93 - $57.75 $1,047 - $1,732
-30 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$29.01 - $72.51 $870 - $2,175
30 New
30 $1,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.